How ENT and allergy practices negotiate better reimbursement rates with payors

ENT and allergy practices operate across a diverse mix of evaluation, procedural, and in-office treatment codes — each with its own rate dynamics and negotiation leverage points.

ENT and allergy practices occupy a distinctive position in the specialty care landscape. Their revenue mix combines the visit-based reimbursement patterns of an office-based specialty with the procedure-driven economics of a surgical subspecialty — and in the case of allergy, the recurring revenue model of immunotherapy. This complexity creates both risk and opportunity in payor contracting: more variables to manage, but also more leverage points in a well-prepared negotiation.

The ENT and allergy revenue mix

For ENT practices, the highest-revenue codes typically span three categories: evaluation and management (E&M) codes for office visits, procedural codes for in-office procedures (endoscopies, biopsies, minor surgical interventions), and surgical codes for OR-based procedures. The relative weighting of these categories varies by practice, but each has its own reimbursement dynamics and negotiating posture.

For allergy practices, immunotherapy codes — including allergy testing, antigen preparation, and injection administration — represent a substantial share of revenue. These codes have specific reimbursement structures that differ significantly from standard procedural codes and require specialized attention in contract negotiations.

Practices that combine ENT and allergy — a common structure in larger groups — must manage both revenue streams effectively and may have different rate positions in each with the same payor.

Where the data reveals the most opportunity

Procedural codes in competitive markets

In markets with multiple large ENT practices, procedural code rates show the most variation — and therefore the most opportunity. Payors negotiate differently with practices that have demonstrated willingness to walk away from unfavorable terms, and the benchmarking data frequently reveals that practices with similar volume profiles are being paid very different rates for the same in-office procedures.

Allergy immunotherapy rates

Immunotherapy codes are often under-negotiated simply because they are less visible than E&M and surgical codes. Practices that have never specifically focused a negotiation on their allergy reimbursement schedule frequently find meaningful improvement available — particularly from payors that have not revisited allergy rates in several contract cycles.

Facility vs. non-facility rate structures

For ENT groups that operate in both office and ambulatory surgery center (ASC) settings, the distinction between facility and non-facility rates is critical. Failing to negotiate both rate types effectively — or allowing a payor to apply unfavorable rate methodology to ASC procedures — can represent a significant revenue leak that only becomes visible when compared against properly benchmarked peer data.

WHAT WE SEE ACROSS ENT AND ALLERGY MARKETS
Practices that have been with the same payors for multiple contract cycles — without renegotiating from a market data foundation — are frequently sitting well below what their market peers are receiving. This is particularly common in markets dominated by one or two large health systems, where independent practices have historically assumed that hospital-affiliated providers command the best rates. The data often tells a different story.

Strategic considerations for large ENT and allergy groups

Health system partnership negotiations

Large ENT and allergy groups are attractive partners for health systems building outpatient networks. Understanding your rate position — and the health system's — before entering partnership discussions is essential. Practices that enter these negotiations with clear benchmarking data are able to protect their contract rates and avoid the "harmonization" pressure that often accompanies health system affiliations.

Market expansion

For multi-state ENT and allergy groups considering new market entry, payor rate analysis provides a pre-entry revenue model that is grounded in actual disclosed rates rather than projections. Understanding which markets offer competitive commercial reimbursement for ENT and allergy codes — before committing capital to a new location — is a meaningful competitive advantage.

Provider recruitment

Recruiting top ENT and allergy physicians into a group practice requires demonstrating that the practice's economics compare favorably to alternatives. Showing a prospective recruit the practice's rate position relative to the market — including what below-market contracts at a competitor look like — is a powerful recruitment tool that very few practices are currently using.